Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-2,482,273
Closed -$69.6M 4172
2016
Q4
$69.6M Sell
2,482,273
-224,024
-8% -$6.28M 0.15% 173
2016
Q3
$74.3M Buy
2,706,297
+751,888
+38% +$20.6M 0.12% 156
2016
Q2
$42.6M Buy
1,954,409
+1,308,198
+202% +$28.5M 0.1% 254
2016
Q1
$14.4M Buy
646,211
+599,049
+1,270% +$13.4M 0.04% 628
2015
Q4
$1.3M Sell
47,162
-79,085
-63% -$2.19M ﹤0.01% 2165
2015
Q3
$3.26M Sell
126,247
-397,400
-76% -$10.3M 0.01% 1601
2015
Q2
$13M Buy
+523,647
New +$13M 0.02% 825
2015
Q1
Sell
-37,667
Closed -$884K 4592
2014
Q4
$884K Buy
+37,667
New +$884K ﹤0.01% 2572
2014
Q3
Sell
-116,152
Closed -$2.84M 4390
2014
Q2
$2.84M Buy
116,152
+49,943
+75% +$1.22M 0.01% 1551
2014
Q1
$1.4M Sell
66,209
-367,914
-85% -$7.76M ﹤0.01% 2027
2013
Q4
$10.3M Buy
+434,123
New +$10.3M 0.03% 693
2013
Q3
Sell
-32,400
Closed -$645K 3868
2013
Q2
$645K Buy
+32,400
New +$645K ﹤0.01% 2206

Other funds holding QGENF

Israel Englander's QGENF Position: Q1 2017 in Review

Israel Englander sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 2,482,273 shares — an estimated $69.6M sold.

Israel Englander first reported a position in QGENF in Q2 2013 and held it in 12 quarters. The position peaked at $74.3M in Q3 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Israel Englander reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Israel Englander sold 2,482,273 QIAGEN NV shares in Q1 2017, an estimated $69.6M.
  • Israel Englander first reported a position in QIAGEN NV in Q2 2013 and held it in 12 quarters.
  • Israel Englander's QIAGEN NV position peaked at $74.3M in Q3 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Millennium Management's 13F filing for Q1 2017, filed 15 May 2017.